Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])

NCT05741710 is registered in ClinicalTrials.gov with Transcend Therapeutics as lead sponsor.

NCT NCT05741710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05741710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
Lead sponsor
Transcend Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2023
Completion date
February 19, 2025
Enrollment
79 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder